Literature DB >> 7509282

Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index cases.

E Lissen1, H J Alter, M A Abad, Y Torres, M Pérez-Romero, M Leal, J A Pineda, R Torronteras, A Sánchez-Quijano.   

Abstract

To define the role of sexual transmission in the spread of hepatitis C virus (HCV) infection, a seroprevalence study of antibodies against HCV was performed in populations at high risk for sexually transmitted diseases. Subjects included 310 female prostitutes, 88 clients of prostitutes, 168 homosexual men and 147 stable heterosexual partners of index cases reactive for anti-HCV (98 of whom were partners of drug addicts coinfected with HCV and human immunodeficiency virus [HIV]). All subjects denied prior transfusion or intravenous drug use. Controls were 400 voluntary blood donors selected randomly from first-time donors. The prevalence of anti-HCV by enzyme immunoassay, confirmed by a second-generation recombinant immunoblot assay, was 6.4% in prostitutes, 6.8% in clients of prostitutes, 4.2% in homosexual men, 7.4% in heterosexual partners of index cases and 1.2% in random donors. However, the anti-HCV prevalence in stable heterosexual partners of HCV-positive/HIV-positive index cases was 2.2 times higher than in stable heterosexual partners of index cases reactive for anti-HCV only (9.2% vs. 4.1%), and sexual partners of index cases coinfected with HCV and HIV were almost three times more likely to be infected with HIV than with HCV (25.5% vs. 9.2%). These data suggest that HCV infection may be sexually transmitted but with low efficiency and that this efficiency could be increased in the presence of coexistent HIV infection in the index case.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7509282     DOI: 10.1007/bf02000402

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  18 in total

1.  Transmission of hepatitis C virus.

Authors: 
Journal:  Ann Intern Med       Date:  1990-09-01       Impact factor: 25.391

2.  Hepatitis C virus: evidence for sexual transmission.

Authors:  R S Tedder; R J Gilson; M Briggs; C Loveday; C H Cameron; J A Garson; G E Kelly; I V Weller
Journal:  BMJ       Date:  1991-06-01

3.  Possibility of heterosexual transmission of hepatitis C virus.

Authors:  G Cilla; E Pérez-Trallero; M Iturriza; J Arrizabalaga; J A Iribarren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-06       Impact factor: 3.267

4.  Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis.

Authors:  M J Alter; P J Coleman; W J Alexander; E Kramer; J K Miller; E Mandel; S C Hadler; H S Margolis
Journal:  JAMA       Date:  1989-09-01       Impact factor: 56.272

5.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

6.  Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection.

Authors:  M J Alter; S C Hadler; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; L A Moyer; H A Fields; D W Bradley
Journal:  JAMA       Date:  1990-11-07       Impact factor: 56.272

7.  Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV.

Authors:  J Tor; J M Llibre; M Carbonell; R Muga; A Ribera; V Soriano; B Clotet; M Sabriá; M Foz
Journal:  BMJ       Date:  1990-11-17

8.  Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Authors:  M E Eyster; H J Alter; L M Aledort; S Quan; A Hatzakis; J J Goedert
Journal:  Ann Intern Med       Date:  1991-11-15       Impact factor: 25.391

9.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

Authors:  M J Alter; H S Margolis; K Krawczynski; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; M A Gerber; R E Sampliner
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

10.  Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users.

Authors:  P Simmonds; L Q Zhang; H G Watson; S Rebus; E D Ferguson; P Balfe; G H Leadbetter; P L Yap; J F Peutherer; C A Ludlam
Journal:  Lancet       Date:  1990-12-15       Impact factor: 79.321

View more
  12 in total

1.  A study on the role of the family and other risk factors in HCV transmission.

Authors:  S Brusaferro; F Barbone; P Andrian; G Brianti; L Ciccone; A Furlan; D Gnesutta; S Stel; E Zamparo; P Toniutto; P Ferroni; V Gasparini
Journal:  Eur J Epidemiol       Date:  1999-02       Impact factor: 8.082

2.  HCV status knowledge and risk behaviours amongst intravenous drug users.

Authors:  G Vidal-Trécan; J Coste; I Varescon-Pousson; B Christoforov; A Boissonnas
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

3.  Sexual transmission of hepatitis C virus infection.

Authors:  G Scotto; A M Savastano; V Fazio; P E Conte; S Ferrara; A Mangano; G Tantimonaco
Journal:  Eur J Epidemiol       Date:  1996-06       Impact factor: 8.082

4.  Risk factors for hepatitis C virus infection among blood donors in an HIV-epidemic area in Thailand.

Authors:  P Sawanpanyalert; S Boonmar; T Maeda; Y Matsuura; T Miyamura
Journal:  J Epidemiol Community Health       Date:  1996-04       Impact factor: 3.710

Review 5.  Sexual transmission of hepatitis C virus infection.

Authors:  G Rooney; R J Gilson
Journal:  Sex Transm Infect       Date:  1998-12       Impact factor: 3.519

Review 6.  Viruses in the mammalian male genital tract and their effects on the reproductive system.

Authors:  N Dejucq; B Jégou
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

7.  Measures to reduce HIV infection have not been successful to reduce the prevalence of HCV in intravenous drug users.

Authors:  I Hernandez-Aguado; J M Ramos-Rincon; M J Aviñio; J Gonzalez-Aracil; S Pérez-Hoyos; M G de la Hera
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

8.  Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.

Authors:  O E Santana Rodríguez; M L Malé Gil; J F HernándezSantana; J M Limiñana Cañal; A M Martín Sánchez
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

9.  Association between hepatitis C virus seroreactivity and HIV infection in non-intravenous drug abusing prostitutes.

Authors:  J A Pineda; A Rivero; C Rey; J Hernández-Quero; A Vergara; J Muñoz; I Aguado; J Santos; R Torronteras; J A Gallardo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-05       Impact factor: 3.267

Review 10.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.